Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Regulatory News | 16 January 2017 | By Zachary Brennan
The European Medicines Agency (EMA) on Monday disclosed a new list of eligible industry stakeholder organizations that can consult and cooperate with the agency in specific areas.
The list of 17 organizations includes the trade groups European Federation of Pharmaceutical Industries and Associations (EFPIA), Medicines for Europe and the Active Pharmaceutical Ingredients Committee.
EMA notes that in order to be more directly involved in EMA activities, industry stakeholders will need to be deemed eligible for engaging in consultative dialogue and cooperation in specific areas, though any industry organization or association may register as an interested party by writing to email@example.com.
Nonprofits that fulfil the following eligibility criteria may apply:
List of eligible industry stakeholder organisations
Eligibility criteria for involvement in EMA activities
Tags: drug industry stakeholders